Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Actuate Therapeutics Inc.
Bristol-Myers Squibb
Hoffmann-La Roche
Mayo Clinic
Merck Sharp & Dohme LLC
Day One Biopharmaceuticals, Inc.
Apollomics Inc.
Hoffmann-La Roche
Cambridge University Hospitals NHS Foundation Trust
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)